(3aR,3'aR,8aS,8'aS)-2,2'-Cyclohexylidenebis[3a,8a-dihydro-dihydro-8H-indeno[1,2-d]oxazole, 97%, 100mg

(R)-3-Cyclohexyl-2-hydroxypropanoic acid, 95%, 500mg

2-Amino-5-chlorobenzaldehyde, 95.0%, 10g

Colonne capillaire GC ROTI®Cap-1701, 25 m, 0,53 mm, 1,00 µm, 1 pièce(s)

tert-Butyl ((2R,3R)-4-(4-acetamido-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate, 99%, 1g

3'-Trifluoromethylbiphenyl-2-carbaldehyde, 95.0%, 250mg

3-Phenethylphenol, 95%, 250mg

Xphos Pd G4, ?98.0%, 5g

3,5-Diiodo-4-methoxybenzonitrile, 97.0%, 1g

3-(10H-phenothiazin-10-yl)propanoic acid, 250mg

1,3,5-Tris(trimethylsilyl)benzene>95.0%(GC)5g

Tert-butyl (5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 98%, 1g

(3-Iodophenyl)methanol, 95.0%, 5g